Effects of MEDI-522 On Disease Activity and Progression of Joint Damage in Patients With Active Rheumatoid Arthritis Suboptimally Responding to Methotrexate

The Center for Rheumatology, Albany

Center for Rheumatology and Bone Research, Wheaton

Sanford S. Hartman, Decatur

Arthritis and Rheumatic Disease Specialty, Aventura

Centre for Rheumatology, Immunology & Arthritis, Fort Lauderdale

Sarasota Arthritis Research Center, Sarasota

Ocala Rheumatology Research Center, Ocala

Gundersen Clinic Ltd., La Crosse

RIMA, St Louis

Arthritis Consultants, Inc., St Louis

Fayetteville Diagnostic Clinic, Ltd., Fayetteville

Health Research Institute, Oklahoma City

Lynn Health Science Institute, Oklahoma City

Oklahoma Center for Arthritis Therapy and Research Inc., Tulsa

Radiant Research, Dallas

Amarillo Center for Clinical Research, Amarillo

Arthritis & Osteoporosis Associates, LLP, Lubbock

University of Utah Medical Hospital, Salt Lake City

Arizona Research & Education, Phoenix

Sun Valley Arthritis Center, Glendale

University of Arizona, Tucson

Boling Clinical Trials, Rancho Cucamonga

Pacific Arthritis Center Medical Group, Santa Maria

Rheumatology Northwest/Clinical Trials Northwest, Yakima

The Physician's Clinic of Spokane, Spokane

The University of Alabama at Birmingham, Birmingham

Thornton Hospital, La Jolla

Rheumatology Associates of New Jersey, Teaneck

University of Wisconsin Hospital & Clinics, Madison

Richmond Health Science Center, Richmond

Manitoba Clinic, Winnipeg

Arthritis Centre, Winnipeg

Centre Inflammatory Arthritis Disease Studies, Winnipeg

Charlton Medical Center, Hamilton

MAC Research, Inc., Hamilton

K-W Musculoskeletal Research, Inc., Kitchener

The Arthritis Program Research Group Inc., Newmarket

Ottawa General Hospital, Ottawa

Rheumatic Disease Center of Montreal, Montreal

Midtown Medical Center, Saskatoon